Goeppert LLC

Goeppert LLC, a self-certified small disadvantaged business based in Philadelphia, Pennsylvania, develops advanced nanomaterials and nanotechnology solutions for federal research agencies, operating exclusively as a prime contractor on small-business set-aside R&D contracts and federal grants. The company competes entirely under small-business set-asides across its portfolio of awards with NASA, the National Institutes of Health, the National Science Foundation, the Department of Defense, and other civilian research agencies.

Goeppert's capability footprint centers on solid-state nanopore technology, two-dimensional materials processing, and microgravity-assisted crystal growth for space-based and terrestrial applications. Representative contract work includes a $1.27 million NASA SBIR Phase II award (Nov 2026) for thin-film lithium niobate single-crystal growth via liquid phase epitaxy aboard the International Space Station; a $994 thousand NASA SBIR Phase III definitive contract (Oct 2023) for in-space production of molybdenum disulfide for silicon back-end-of-line integration; an $881 thousand NASA STTR Phase II award (Dec 2022) developing flight-ready solid-state nanopore technology for spacecraft water monitoring; a $210 thousand Army RDECOM purchase order (Jan 2026) for an aerosolized fentanyl electrochemical nano-sensor for field detection; and a $110 thousand Air Force Research Laboratory purchase order (Jul 2026) for MoS2-based radiation-hardened materials development for defense electronics. Grant work spans the National Center for Advancing Translational Sciences (CFDA 93.350), the National Institute of Environmental Health Sciences, the National Human Genome Research Institute, the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084), and NOAA's SBIR program (CFDA 11.021), with projects addressing AAV capsid quality assessment in gene therapy manufacturing, PFAS environmental detection, DNA sequencing via nanopores, cancer diagnostics through cell-free DNA methylation analysis, and nanoplastic contamination research.

Customer concentration reflects Goeppert's focus on federal research agencies rather than defense production. NASA's Shared Services Center dominates with 15 awards valued at $5.2 million combined potential value (85% of award count); the National Institutes of Health National Human Genome Research Institute holds 4 awards; the Army and Air Force Research Laboratory each contribute one award valued at roughly $210 thousand and $110 thousand respectively. The remaining customer set includes the National Science Foundation, the National Institute of Food and Agriculture, and NOAA. Activity remains modest and episodic: two awards in 2023, two in 2024, four in 2025, and four in 2026 year to date, with combined potential value across all 26 awards totaling $5.5 million. Four awards with combined potential value of $1.5 million face ultimate completion within the next twenty-four months and therefore recompete exposure.